Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000484027 | SCV000565981 | pathogenic | not provided | 2015-03-26 | criteria provided, single submitter | clinical testing | Although the c.3514_3517dupTATA variant in the MYBPC3 gene has not been reported to ourknowledge, this variant causes a shift in reading frame starting at codon Lysine 1173, changing it to anIsoleucine, and creating a premature stop codon at position 2 of the new reading frame, denotedp.Lys1173IlefsX2. This duplication is expected to result in either an abnormal, truncated protein product orloss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift variants in the MYBPC3 gene have been reported in HGMD in association with cardiomyopathy (Stenson P et al., 2014). In summary, c.3514_3517dupTATA in the MYBPC3 gene is interpreted as a pathogenic variant. |